US Patent 11421038 RNA-coded antibody
Patent 11421038 was granted and assigned to CureVac on August, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 8, 2008
Date of Patent
August 23, 2022
Patent Application Number
12522214
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11421038 RNA-coded antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.